Mu-Tai Liu
Impact in
- Radiation top 5%
- Advanced Radiotherapy Techniques
- Radiation Detection and Scintillator Technologies
- Nuclear Physics and Applications
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
-
- Advanced Radiotherapy Techniques 6
- Nuclear Physics and Applications 2
-
- Head and Neck Cancer Studies 5
- Co-authors
- T. L. Chu (4 shared papers)Jao-Perng Lin (3 shared papers)Mu‐Kuan Chen (4 shared papers)Tung‐Hao Chang (7 shared papers)Chao‐Yuan Huang (4 shared papers)Pei‐Yi Chu (1 shared paper)Chang‐Yao Hsieh (3 shared papers)Cheng‐Ching Yu (2 shared papers)
- Journals
- Applied Radiation and Isotopes (5 papers)Radiation Measurements (2 papers)World Journal of Oncology (1 paper)Advances in Therapy (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Mu-Tai Liu
23 papers receiving 393 citations
Peers
Comparison fields: 5 of 43
- Radiation 132
- Otorhinolaryngology 49
- Hepatology 67
- Pulmonary and Respiratory Medicine 128
- Radiology, Nuclear Medicine and Imaging 56
Countries citing papers authored by Mu-Tai Liu
This map shows the geographic impact of Mu-Tai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Tai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Tai Liu more than expected).
Fields of papers citing papers by Mu-Tai Liu
This network shows the impact of papers produced by Mu-Tai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Tai Liu. The network helps show where Mu-Tai Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu-Tai Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 78 | |
| 2 | 2001 | 56 | |
| 3 | Small cell carcinoma of the head and neck: a single institution's experience and review of the literature. | 2008 | 32 |
| 4 | 2005 | 31 | |
| 5 | 2001 | 29 | |
| 6 | 2002 | 21 | |
| 7 | 2010 | 19 | |
| 8 | Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). | 1998 | 18 |
| 9 | 2011 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2003 | 15 | |
| 12 | 2015 | 14 | |
| 13 | 2010 | 12 | |
| 14 | 2006 | 11 | |
| 15 | 2010 | 9 | |
| 16 | 2004 | 6 | |
| 17 | 2001 | 5 | |
| 18 | 2011 | 4 | |
| 19 | 2014 | 3 | |
| 20 | 2008 | 2 |
About Mu-Tai Liu
Mu-Tai Liu is a scholar working on Radiation, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 24 papers that have together received 403 indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (6 papers), Head and Neck Cancer Studies (5 papers), Radiation Therapy and Dosimetry (4 papers), Radiation Dose and Imaging (4 papers), Nuclear Physics and Applications (2 papers), Advanced X-ray and CT Imaging (1 paper), Sesquiterpenes and Asteraceae Studies (1 paper) and Neurofibromatosis and Schwannoma Cases (1 paper). The work is most often cited by research in Radiation (132 citations), Otorhinolaryngology (49 citations), Hepatology (67 citations), Pulmonary and Respiratory Medicine (128 citations) and Radiology, Nuclear Medicine and Imaging (56 citations). Mu-Tai Liu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include T. L. Chu, Jao-Perng Lin, Mu‐Kuan Chen, Tung‐Hao Chang, Chao‐Yuan Huang, Pei‐Yi Chu, Chang‐Yao Hsieh, Cheng‐Ching Yu, Kai-Lin Hwang and Kao‐Lang Liu. Their work appears in journals such as Applied Radiation and Isotopes, Radiation Measurements, World Journal of Oncology, Advances in Therapy and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.